This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pieris Pharmaceuticals Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Thomas Jaquin: Innovator in Fusion Proteins
Introduction
Thomas Jaquin is a notable inventor based in Erding, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of novel fusion proteins.
Latest Patents
Jaquin holds a patent for "Novel Fusion Proteins Specific for CD137 and GPC3." This innovation showcases his expertise in creating targeted therapies that could have substantial implications in medical treatments.
Career Highlights
Currently, Thomas Jaquin is employed at Pieris Pharmaceuticals GmbH, where he continues to advance his research and development efforts. His work at this company emphasizes the importance of innovative solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Jaquin has collaborated with talented professionals, including Rachida Siham Bel Aiba and Birgit Bossenmaier. These partnerships highlight the collaborative nature of scientific research and innovation.
Conclusion
Thomas Jaquin's contributions to the field of biotechnology, particularly through his patent and work at Pieris Pharmaceuticals GmbH, underscore his role as an influential inventor. His ongoing efforts in developing novel fusion proteins are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile